Cargando…
T cell immunity ameliorates COVID-19 disease severity and provides post-exposure prophylaxis after peptide-vaccination, in Syrian hamsters
BACKGROUND: The emergence of novel SARS-CoV-2 variants that resist neutralizing antibodies drew the attention to cellular immunity and calls for the development of alternative vaccination strategies to combat the pandemic. Here, we have assessed the kinetics of T cell responses and protective effica...
Autores principales: | Somogyi, Eszter, Kremlitzka, Mariann, Csiszovszki, Zsolt, Molnár, Levente, Lőrincz, Orsolya, Tóth, József, de Waal, Leon, Pattijn, Sofie, Reineking, Wencke, Beineke, Andreas, Tőke, Enikő R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9902696/ https://www.ncbi.nlm.nih.gov/pubmed/36761759 http://dx.doi.org/10.3389/fimmu.2023.1111629 |
Ejemplares similares
-
A Peptide Vaccine Candidate Tailored to Individuals' Genetics Mimics the Multi-Targeted T Cell Immunity of COVID-19 Convalescent Subjects
por: Somogyi, Eszter, et al.
Publicado: (2021) -
In Silico Model Estimates the Clinical Trial Outcome of Cancer Vaccines
por: Lőrincz, Orsolya, et al.
Publicado: (2021) -
Safety and Activity of PolyPEPI1018 Combined with Maintenance Therapy in Metastatic Colorectal Cancer: an Open-Label, Multicenter, Phase Ib Study
por: Hubbard, Joleen M., et al.
Publicado: (2022) -
Polyadenine insertion disrupting the G6PC1 gene in German Pinschers with glycogen storage disease type Ia (GSD1A)
por: Christen, Matthias, et al.
Publicado: (2021) -
LYMPHOCYTIC CHORIOMENINGITIS IN THE SYRIAN HAMSTER
por: Smadel, J. E., et al.
Publicado: (1942)